Page last updated: 2024-09-03

maltotetraose and Glycogen Storage Disease Type II

maltotetraose has been researched along with Glycogen Storage Disease Type II in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
de Vries, JM; Goudriaan, DA; Huijmans, JG; Reuser, AJ; Ruijter, GJ; Sluiter, W; van den Bosch, JC; van der Ploeg, AT; van Gelder, CM1

Other Studies

1 other study(ies) available for maltotetraose and Glycogen Storage Disease Type II

ArticleYear
Rapid ultraperformance liquid chromatography-tandem mass spectrometry assay for a characteristic glycogen-derived tetrasaccharide in Pompe disease and other glycogen storage diseases.
    Clinical chemistry, 2012, Volume: 58, Issue:7

    Topics: Adolescent; Adult; Age Factors; Aged; Child; Child, Preschool; Chromatography, Liquid; Glycogen; Glycogen Storage Disease; Glycogen Storage Disease Type II; Glycogen Storage Disease Type III; Glycogen Storage Disease Type IV; Humans; Infant; Infant, Newborn; Maltose; Middle Aged; Oligosaccharides; Reference Values; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry; Young Adult

2012